40 Participants Needed

Exercise for Improved Cognition and Cardiometabolic Health

Recruiting at 3 trial locations
SK
Overseen BySteven K Malin, PhD
Age: 18+
Sex: Any
Trial Phase: Phase 2 & 3
Sponsor: Rutgers, The State University of New Jersey
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial requires that you stop taking certain medications, specifically those for weight suppression and those that affect heart rate and rhythm. If you are on these medications, you would need to discontinue them to participate.

What data supports the effectiveness of the treatment Exercise, Physical Activity, Workout, Fitness Training for improved cognition and cardiometabolic health?

Research shows that regular exercise improves heart health, reduces risk factors for heart disease, and enhances overall quality of life. It also helps control weight, lowers blood pressure, and improves cholesterol levels, which are important for cardiometabolic health.12345

Is exercise generally safe for humans?

Exercise is generally safe for humans, but there can be some risks, especially for people who are not used to physical activity or have existing health issues. Most adverse events are minor, like muscle injuries, and serious problems are rare. It's important to start slowly and gradually increase intensity to minimize risks.678910

How does exercise as a treatment for cognition and cardiometabolic health differ from other treatments?

Exercise is unique because it improves cognition and cardiometabolic health by enhancing brain function and energy metabolism, and it does so without the need for medication. It works by increasing brain-derived neurotrophic factor, which supports brain health and plasticity, and it can be combined with dietary changes for even greater benefits.1112131415

What is the purpose of this trial?

Dementia is a leading cause of death in the United States among aging adults. Brain insulin resistance has emerged as a pathologic factor affecting memory, executive function as well as systemic glucose control. Regular aerobic exercise decreases Alzheimer's Disease (AD) risk, in part, through changes in brain structure and function. However, there is limited data available on how exercise impacts brain insulin resistance in aging. This study will test the effect of acute exercise on brain insulin sensitivity in middle-aged to older adults. The study will also examine cognition and cardiometabolic health in relation to brain insulin sensitivity.

Research Team

SK

Steven K Malin, PhD

Principal Investigator

Rutgers University - New Brunswick

Eligibility Criteria

This trial is for men and women aged 40-80 who are not very active (less than 150 minutes of exercise per week), have a BMI between 25 and 45, but aren't pregnant or nursing. It's not for those with serious health issues, recent smokers, or people on certain medications that affect weight or heart rate.

Inclusion Criteria

Your body mass index is between 25 and 45 kg/m2.
I am between 40 and 80 years old.
You do not engage in at least 150 minutes of moderate to high-intensity exercise per week.
See 2 more

Exclusion Criteria

You have had a significant weight change of more than 2 kilograms in the past 3 months.
You have a history of serious health conditions that could affect the study results or your safety.
I am currently on medication that affects my heart rate or rhythm.
See 9 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants undergo baseline assessments including MRI arterial spin labeling and cognitive testing

1 week
1 visit (in-person)

Intervention

Participants either rest or exercise at medium to hard intensity for 1 hour

1 week
1 visit (in-person)

Follow-up

Participants are monitored for changes in brain insulin sensitivity, cognition, and cardiometabolic health

1 week
1 visit (in-person)

Treatment Details

Interventions

  • Exercise
Trial Overview The study investigates how a single session of exercise affects brain insulin sensitivity in middle-aged to older adults. It also looks at the relationship between this sensitivity, cognition, and overall cardiometabolic health.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: ExerciseExperimental Treatment1 Intervention
Individuals will exercise for at medium to hard intensity for 1 hour.
Group II: RestActive Control1 Intervention
Individuals will rest for about 1 hour in the seated position to mimic time exercising.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rutgers, The State University of New Jersey

Lead Sponsor

Trials
471
Recruited
81,700+

Findings from Research

Regular exercise significantly increases markers of exercise capacity, such as VO2max and ventilatory threshold (VT), which can enhance overall quality of life, especially for patients with health limitations.
Exercise serves as a positive health recommendation that not only improves physical fitness but may also indirectly encourage patients to adopt healthier behaviors, contrasting with traditional negative health advice.
Physical activity and exercise training prescriptions for patients.Foster, C., Cadwell, K., Crenshaw, B., et al.[2019]
Regular exercise significantly benefits patients with heart disease by improving exercise tolerance, controlling risk factors, and potentially influencing the progression of coronary artery disease.
Patients should follow physician-guided exercise plans that include dynamic endurance activities and moderate-intensity circuit weight training, with a recommended duration of 2 to 3 hours per week, while high-risk patients should exercise at lower intensities.
[Heart patient and sports].Niederhauser, HU.[2008]
Regular physical activity significantly reduces cardiovascular risk and mortality, with even low levels of exercise providing substantial health benefits for individuals, including those at high risk for cardiovascular events.
While exercise is generally safe, it can temporarily increase the risk of cardiovascular events during acute physical activity; however, these events are rare and can be mitigated through proper screening programs.
Exercise: friend or foe?Dangardt, FJ., McKenna, WJ., Lรผscher, TF., et al.[2022]

References

Physical activity and exercise training prescriptions for patients. [2019]
[Heart patient and sports]. [2008]
Exercise: friend or foe? [2022]
[Exercise therapy of atherosclerosis]. [2011]
[Cardiorespiratory fitness. Importance of sports for health]. [2006]
Adverse events in mobility-limited and chronically ill elderly adults participating in an exercise intervention study supported by general practitioner practices. [2015]
Adverse events among high-risk participants in a home-based walking study: a descriptive study. [2022]
Researchers' perspectives on adverse event reporting in resistance training trials: a qualitative study. [2022]
Screening, safety, and adverse events in physical activity interventions: collaborative experiences from the behavior change consortium. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Putting the benefits and risks of aerobic exercise in perspective. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Exercise, cognition, and the aging brain. [2022]
Mind body exercise improves cognitive function more than aerobic- and resistance exercise in healthy adults aged 55 years and older - an umbrella review. [2023]
13.United Statespubmed.ncbi.nlm.nih.gov
The influence of exercise on cognitive abilities. [2022]
Insulin Homeostasis Mediates the Relationship Between Cardiorespiratory Fitness and Cognitive Speed in Aging Adults. [2023]
15.United Statespubmed.ncbi.nlm.nih.gov
Physical activity in relation to cognitive decline in elderly men: the FINE Study. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity